A multicenter, randomized, double-blind, placebo-controlled, parallel group, one-year study of the efficacy and safety of topiramate in the treatment of obese subjects with dyslipidemia.

Trial Profile

A multicenter, randomized, double-blind, placebo-controlled, parallel group, one-year study of the efficacy and safety of topiramate in the treatment of obese subjects with dyslipidemia.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 03 May 2010

At a glance

  • Drugs Topiramate (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jun 2009 Actual patient number (21) added as reported by ClinicalTrials.gov.
    • 23 Jun 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 05 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top